Medicare Enrolled
Dr. Young Kang, MD
Optician · Pleasanton, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kang
Dr. Young Kang is an optician specialist in Pleasanton, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kang performed 6,641 Medicare services across 3,994 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kang received a total of $4,021 from 20 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in CA
$4,021 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,641
Medicare services
Top 13% in CA for optician
3,994
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~332 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,526 | $2 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,276 | $106 | $278 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
1,140 | $11 | $174 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
671 | $10 | $153 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
375 | $109 | $198 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
292 | $145 | $288 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
282 | $33 | $334 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
184 | $132 | $320 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
154 | $147 | $310 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
148 | $225 | $832 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $137 | $800 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
102 | $69 | $124 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
71 | $138 | $271 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
53 | $22 | $302 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
43 | $60 | $257 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
40 | $33 | $195 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
29 | $72 | $242 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $20 | $75 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
26 | $707 | $1,500 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
23 | $113 | $826 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
19 | $435 | $1,284 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $338 | $935 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
19 | $226 | $547 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
22.8% medium
76.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,021
Total received (2018-2024)
Avg $574/year across 7 years
Top 27% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$2,016 (50.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,889 (47.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$116 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,206
2023
$511
2022
$517
2021
$27
2020
$78
2019
$337
2018
$344
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$2,016
IMMUNITYBIO, INC.
$117
PFIZER INC.
$22
Sumitomo Pharma America, Inc.
$22
UROGEN PHARMA, INC.
$16
Astellas Pharma US Inc
$13
Top 3 companies account for 97.7% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$2,379
PROCEPT BioRobotics Corporation
$438
Astellas Pharma US Inc
$389
Boston Scientific Corporation
$193
Janssen Biotech, Inc.
$125
IMMUNITYBIO, INC.
$117
Dornier MedTech America, Inc
$61
Sumitomo Pharma America, Inc.
$61
Axonics, Inc.
$45
AbbVie Inc.
$40
Bayer HealthCare Pharmaceuticals Inc.
$23
PFIZER INC.
$22
Dendreon Pharmaceuticals LLC
$20
BOSTON SCIENTIFIC CORPORATION
$19
Endo Pharmaceuticals Inc.
$17
UROGEN PHARMA, INC.
$16
Myriad Genetic Laboratories, Inc.
$16
Rochester Medical Corporation
$15
Sagent Pharmaceuticals, Inc.
$13
Allergan Inc.
$11
Top 3 companies account for 79.7% of all-time payments
Associated products mentioned in payments ›
ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AquaBeam Robotic System · BOTOX THERAPEUTIC · Bulkamid · Dornier MedTech · GEMTESA · GENERAL - KIDNEY STONE DISEASE · Glydo · JELMYTO · LITHOVUE · LUPRON DEPOT · MYRBETRIQ · Nubeqa · OES CYSTONEPHROFIBERSCOPE · Olympus Stone Baskets and Retrievers · PROVENGE · Prolaris · RETROMAX · REZUM · SpaceOAR VUE System - 10mL · XIAFLEX · XTANDI · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
Opticians within 10 mi
545
Per 100K population
33.0
County median income
$126,240
Nearest hospital
STANFORD HEALTH CARE TRI-VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kang is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with mixed engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kang experienced with automated urinalysis?
Based on Medicare claims data, Dr. Kang performed 1,526 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kang receive payments from pharmaceutical companies?
Yes. Dr. Kang received a total of $4,021 from 20 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kang's costs compare to other opticians in Pleasanton?
Dr. Kang's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Pleasanton
Browse opticians in Pleasanton ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Olympus America Inc. Payments to Doctors
See all physicians who received payments from Olympus America Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology